E-Learning

Institutional biosafety committee oversight is necessary to ensure the safety of those involved in research with engineered genetic materials.

Advarra recognizes clinical research institutions for their extraordinary response to the COVID-19 pandemic. COVID-19 has created unique challenges, forcing clinical and operational staff to navigate an unprecedented research environment. Clinical trials have been impacted by re-prioritization of resources, staff furloughs and reassignments, and new policies and procedures.